BMRN BIOMARIN PHARMACEUTICAL INC
Nasdaq · SEC CIK 1048477 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.32M 5 sales by 3 insiders
- Filings on record
- 231 since 2021-07-19, latest 2026-09-14 18:55
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Davis George Eric | EVP, CLO | — | $2.76M |
| Guyer Charles Greg | EVP, Chief Technical Off | — | $996.7K |
| Friberg Gregory R | EVP, Chief R, D Off | — | $558.6K |
| Ramchandani Rashmi Virendra | VP, CAO | — | — |
| Hubbard Cristin | EVP, Chief Commercial Off | — | — |
| Hardy Alexander | CEO, Dir | — | — |
| Plenge Robert M | Dir | — | — |
| ANDERSON ELIZABETH M | Dir | — | — |
| Bodem Barbara W. | Dir | — | — |
| Ho Maykin | Dir | — | — |
Transactions 331
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-17 | 2022-03-15+ | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $78.59 | -9,705 | 68.7K | -12% | -$762.8K |
| D | 2022-03-17 | 2022-03-15 | BMRN | Mueller Brian | EVP, CFO | A - Grant | $0.00 | +11.0K | 40.7K | +37% | $0 |
| DM | 2022-03-17 | 2022-03-15+ | BMRN | Mueller Brian | EVP, CFO | F - Tax | $78.85 | -2,450 | 38.3K | -6% | -$193.2K |
| D | 2022-03-17 | 2022-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $78.27 | -920 | 52.1K | -2% | -$72.0K |
| D | 2022-03-17 | 2022-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.00 | +11.0K | 53.0K | +26% | $0 |
| DM | 2022-03-14 | 2022-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +30.0K | 353.6K | +9% | +$1.12M |
| DM | 2022-03-14 | 2022-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $77.69 | -30.0K | 338.6K | -8% | -$2.33M |
| 2022-03-10 | 2022-03-08 | BMRN | Davis George Eric | EVP, GC | A - Grant | $0.00 | +9,370 | 68.0K | +16% | $0 | |
| 2022-03-10 | 2022-03-08 | BMRN | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +12.8K | 119.3K | +12% | $0 | |
| 2022-03-10 | 2022-03-08 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | A - Grant | $0.00 | +34.8K | 338.6K | +11% | $0 | |
| 2022-03-10 | 2022-03-08 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +9,370 | 65.2K | +17% | $0 | |
| M | 2022-03-02 | 2022-02-28 | BMRN | Slamon Dennis | Dir | S - Sale | $78.33 | -6,396 | 21.6K | -23% | -$501.0K |
| D | 2022-02-28 | 2022-02-25 | BMRN | HERON ELAINE J | Dir | M - OptEx | $37.46 | +8,500 | 80.6K | +12% | +$318.4K |
| 2022-02-07 | 2022-02-03 | BMRN | Mueller Brian | EVP, CFO | F - Tax | $87.77 | -1,072 | 29.7K | -3% | -$94.1K | |
| D | 2022-01-19 | 2022-01-14 | BMRN | LAWLIS V BRYAN | Dir | S - Sale+OE | $87.61 | -4,250 | 24.0K | -15% | -$372.3K |
| D | 2022-01-19 | 2022-01-14 | BMRN | LAWLIS V BRYAN | Dir | M - OptEx | $37.46 | +4,250 | 28.2K | +18% | +$159.2K |
| DM | 2022-01-14 | 2022-01-12+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $88.43 | -10.0K | 303.8K | -3% | -$884.3K |
| D | 2022-01-14 | 2021-12-21 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | L - Small Acq | $89.22 | +100 | 303.8K | +0.0% | +$8,922 |
| DM | 2022-01-14 | 2022-01-12+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +10.0K | 308.8K | +3% | +$374.6K |
| 2022-01-05 | 2022-01-03 | BMRN | Alles Mark J | Dir | A - Grant | $0.00 | +2,300 | 2,300 | New | $0 | |
| DM | 2021-12-17 | 2021-12-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $83.69 | -12.0K | 303.7K | -4% | -$1.00M |
| DM | 2021-12-17 | 2021-12-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +12.0K | 309.7K | +4% | +$449.5K |
| D | 2021-12-17 | 2021-12-10 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | G - Gift | $0.00 | -700 | 303.7K | -0.2% | $0 |
| 2021-12-02 | 2021-12-01 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale | $87.22 | -1,500 | 304.4K | -0.5% | -$130.8K | |
| 2021-12-02 | 2021-09-09 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | L - Small Acq | $78.77 | +50 | 305.9K | +0.0% | +$3,938 | |
| 2021-10-28 | 2021-10-26 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $73.60 | -2,739 | 55.9K | -5% | -$201.6K | |
| 2021-10-28 | 2021-04-30 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $62.41 | +342 | 58.6K | +0.6% | +$21.3K | |
| D | 2021-10-22 | 2021-10-20 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +1,000 | 305.8K | +0.3% | +$37.5K |
| 2021-08-04 | 2021-08-02 | BMRN | Davis George Eric | EVP, GC | S - Sale | $76.69 | -5,518 | 58.6K | -9% | -$423.2K | |
| 2021-07-19 | 2021-07-16 | BMRN | Acosta Andrea | CAO, GVP | F - Tax | $78.84 | -285 | 18.1K | -2% | -$22.5K | |
| 2021-07-19 | 2021-04-30 | BMRN | Acosta Andrea | CAO, GVP | A - Grant | $62.41 | +271 | 18.4K | +1% | +$16.9K |
Purchase Sale Sale after option exercise All abbreviations